ELMD vs PATH · P/E 33, rev $64.0M vs P/E 19, rev $1.61B
Electromed Inc (ELMD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Electromed Inc (ELMD) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ELMD revenue for 2025-06-30 was $64.0M. Net income was $7.5M. Revenue was up 17.0% from 2024-06-30 to 2025-06-30. ELMD currently screens at market cap $316.8M and trailing P/E 32.7.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ELMD currently screens at market cap $316.8M and trailing P/E 32.7. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ELMD and PATH stock pages for the full models.
Not investment advice.